FDA Drug Application (019675) for ZANTAC by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number019675
Product Number001
FormSYRUP;ORAL
DosageEQ 15MG BASE/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameZANTAC
Active IngredientRANITIDINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient RANITIDINE HYDROCHLORIDE7


Back to FDA Applications sponsored by GLAXO GRP LTD